G1 Therapeutics diskutieren
G1 Therapeutics
WKN: A2DR0J / Symbol: GTHX / Name: G1 Therapeutics / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
4,14 €
17,91 %
G1 Therapeutics, Inc. (NASDAQ: GTHX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $11.00 price target on the stock.
Ratings data for GTHX provided by MarketBeat
G1 Therapeutics, Inc. (NASDAQ: GTHX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $18.00 price target on the stock.
Ratings data for GTHX provided by MarketBeat
G1 Therapeutics, Inc. (NASDAQ: GTHX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $11.00 price target on the stock.
Ratings data for GTHX provided by MarketBeat
G1 Therapeutics, Inc. (NASDAQ: GTHX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $5.00 price target on the stock.
Ratings data for GTHX provided by MarketBeat
G1 Therapeutics, Inc. (NASDAQ: GTHX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $14.00 price target on the stock.
Ratings data for GTHX provided by MarketBeat
G1 Therapeutics, Inc. (NASDAQ: GTHX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $5.00 price target on the stock.
Ratings data for GTHX provided by MarketBeat
G1 Therapeutics, Inc. (NASDAQ: GTHX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $14.00 price target on the stock.
Ratings data for GTHX provided by MarketBeat
G1 Therapeutics, Inc. (NASDAQ: GTHX) had its price target lowered by analysts at Wedbush from $5.00 to $4.00. They now have an "outperform" rating on the stock.
Ratings data for GTHX provided by MarketBeat
G1 Therapeutics, Inc. (NASDAQ: GTHX) had its price target lowered by analysts at Needham & Company LLC from $14.00 to $12.00. They now have a "buy" rating on the stock.
Ratings data for GTHX provided by MarketBeat
G1 Therapeutics, Inc. (NASDAQ: GTHX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $12.00 price target on the stock.
Ratings data for GTHX provided by MarketBeat
G1 Therapeutics, Inc. (NASDAQ: GTHX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $5.00 price target on the stock, up previously from $4.00.
Ratings data for GTHX provided by MarketBeat
G1 Therapeutics, Inc. (NASDAQ: GTHX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $12.00 price target on the stock.
Ratings data for GTHX provided by MarketBeat
G1 Therapeutics, Inc. (NASDAQ: GTHX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $12.00 price target on the stock.
Ratings data for GTHX provided by MarketBeat
G1 Therapeutics, Inc. (NASDAQ: GTHX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
Ratings data for GTHX provided by MarketBeat
Neueste Beiträge
Wedbush in Scholar Rock Holding diskutieren